Meitav Dash Investments LTD Chemomab Therapeutics Ltd. Transaction History

Meitav Dash Investments LTD

  • $4.92 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022
SELL
$3.53 - $7.2 $8,976 - $18,309
-2,543 Reduced 6.77%
35,024 $167,000
Q3 2021

Nov 03, 2021
SELL
$11.08 - $19.17 $34,314 - $59,369
-3,097 Reduced 7.62%
37,567 $416,000
Q2 2021

Aug 05, 2021
BUY
$16.07 - $55.0 $519,912 - $1.78 Million
32,353 Added 389.28%
40,664 $773,000
Q1 2021

May 06, 2021
BUY
$27.2 - $127.36 $226,059 - $1.06 Million
8,311 New
8,311 $239,000

Others Institutions Holding CMMB

# of Institutions
16
Shares Held
2.66M
Call Options Held
0
Put Options Held
0
View Full List

About Chemomab Therapeutics Ltd.

CMMB Quotes by TradingView
  • Ticker CMMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,431,700
  • Market Cap $11.2M
  • Description
  • Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...
More about CMMB
Track This Portfolio

Track Meitav Dash Investments LTD Portfolio

Follow Meitav Dash Investments LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Meitav Dash Investments LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email